The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ryzhova M.V.

Burdenko Neurosurgical Center

Galstyan S.A.

Burdenko Neurosurgical Center

Shishkina L.V.

Burdenko Neurosurgical Center

Panina T.N.

Burdenko Neurosurgical Center

Voronina E.I.

Federal Center of Neurosurgery

Telysheva E.N.

Burdenko Neurosurgical Center

Kotelnikova A.O.

Burdenko Neurosurgical Center

Starovoitov D.V.

Burdenko National Medical Research Center of Neurosurgery

Shaikhaev E.G.

Burdenko Neurosurgical Center

Snigireva G.P.

Burdenko Neurosurgical Center

Sycheva R.V.

Burdenko Neurosurgical Center

Kadyrov Sh.U.

Burdenko Neurosurgical Center

Adaev A.R.

Burdenko Neurosurgical Center

Pitskhelauri D.I.

Skolkovo Institute of Science and Technology

Kudieva E.S.

Burdenko Neurosurgical Center

Zheludkova O.G.

V.F. Voyno-Yasenetsky Scientific and Practical Center of Specialized Medical Care for Children

Golanov A.V.

Burdenko Neurosurgical Center

Astrocytoma with 1p19q codeletion

Authors:

Ryzhova M.V., Galstyan S.A., Shishkina L.V., Panina T.N., Voronina E.I., Telysheva E.N., Kotelnikova A.O., Starovoitov D.V., Shaikhaev E.G., Snigireva G.P., Sycheva R.V., Kadyrov Sh.U., Adaev A.R., Pitskhelauri D.I., Kudieva E.S., Zheludkova O.G., Golanov A.V.

More about the authors

Read: 2156 times


To cite this article:

Ryzhova MV, Galstyan SA, Shishkina LV, et al. . Astrocytoma with 1p19q codeletion. Russian Journal of Archive of Pathology. 2023;85(1):51‑56. (In Russ.)
https://doi.org/10.17116/patol20238501151

References:

  1. IARC Publications. WHO Classification of Tumours. Central nervous system tumours. 5th ed. Vol.6. Lyon: International Agency for Research on Cancer; 2021. https://publications.iarc.fr/601
  2. Gupta R, Webb-Myers R, Flanagan S, Buckland ME. Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications. J Clin Pathol. 2011;64(10):835-844.  https://doi.org/10.1136/jclinpath-2011-200227
  3. Leu S, von Felten S, Frank S, Boulay JL, Mariani L. IDH mutation is associated with higher risk of malignant transformation in low-grade glioma. J Neurooncol. 2016;127(2):363-372.  https://doi.org/10.1007/s11060-015-2048-y
  4. Han CH, Batchelor TT. Isocitrate dehydrogenase mutation as a therapeutic target in gliomas. Chin Clin Oncol. 2017;6(3):33.  https://doi.org/10.21037/cco.2017.06.11
  5. Waker CA, Lober RM. Brain tumors of glial origin. Adv Exp Med Biol. 2019;1190:281-297.  https://doi.org/10.1007/978-981-32-9636-7_18
  6. Li YX, Shi Z, Aibaidula A, Chen H, Tang Q, Li KK, Chung NY, Chan DT, Poon WS, Mao Y, et al. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic. Oncotarget. 2016;7(40): 64615-64630. https://doi.org/10.18632/oncotarget.11378
  7. Andrews C, Prayson RA. 1p/19q co-deleted fibrillary astrocytomas: not everything that is co-deleted is an oligodendroglioma. Ann Diagn Pathol. 2020;46:151519. https://doi.org/10.1016/j.anndiagpath.2020.151519

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.